Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation

Biochemical and Biophysical Research Communications

Volumn 413, Issue 4, 2011, Pages 616-622

  Cho, Sunglim ^a   Jun, Youngsoo ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Antigen presentation; CD1d; Human cytomegalovirus; Natural killer T cell; US11

Indexed keywords

CD1D ANTIGEN; COMPLEMENTARY DNA; GENE PRODUCT; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANTIGEN PRESENTATION; ANTIGENS, CD1D; CELL MEMBRANE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; RNA-BINDING PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 80053611818     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.013     Document Type: Article

References (30)

1. Barral D.C., Brenner M.B. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 2007, 7:929-941.
2. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C., Pellicci D.G., Koh R., Besra G.S., Bharadwaj M., Godfrey D.I., McCluskey J., Rossjohn J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007, 448:44-49.
3. Brutkiewicz R.R., Bennink J.R., Yewdell J.W., Bendelac A. TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 1995, 182:1913-1919.
4. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., Brenner M.B. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994, 372:691-694.
5. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003, 4:1230-1237.
6. Grubor-Bauk B., Simmons A., Mayrhofer G., Speck P.G. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J. Immunol. 2003, 170:1430-1434.
7. De Santo C., Salio M., Masri S.H., Lee L.Y., Dong T., Speak A.O., Porubsky S., Booth S., Veerapen N., Besra G.S., Grone H.J., Platt F.M., Zambon M., Cerundolo V. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 2008, 118:4036-4048.
8. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., De Saint Basile G., Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110-114.
9. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415.
10. Bennett E.M., Bennink J.R., Yewdell J.W., Brodsky F.M. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 1999, 162:5049-5052.
11. Schaefer M.R., Wonderlich E.R., Roeth J.F., Leonard J.A., Collins K.L. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog. 2008, 4:e1000131.
12. Moll M., Andersson S.K., Smed-Sorensen A., Sandberg J.K. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010, (116):1876-1884.
13. Rao P., Pham H.T., Kulkarni A., Yang Y., Liu X., Knipe D.M., Cresswell P., Yuan W. Herpes Simplex Virus 1 Glycoprotein B and US3 Collaborate To Inhibit CD1d Antigen Presentation and NKT Cell Function. J. Virol. 2011, (85):8093-8104.
14. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996, 84:769-779.
15. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
16. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997, 6:613-621.
17. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 1996, 93:10990-10995.
18. Raftery M.J., Hitzler M., Winau F., Giese T., Plachter B., Kaufmann S.H., Schonrich G. Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 2008, 82:4308-4319.
19. Lilley B.N., Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004, 429:834-840.
20. Story C.M., Furman M.H., Ploegh H.L. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. Proc. Natl. Acad. Sci. USA 1999, 96:8516-8521.
21. Balk S.P., Bleicher P.A., Terhorst C. Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule. Proc. Natl. Acad. Sci. USA 1989, 86:252-256.
22. Mueller B., Lilley B.N., Ploegh H.L. SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER. J. Cell Biol. 2006, 175:261-270.
23. Loureiro J., Lilley B.N., Spooner E., Noriega V., Tortorella D., Ploegh H.L. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature 2006, 441:894-897.
24. Stagg H.R., Thomas M., van den Boomen D., Wiertz E.J., Drabkin H.A., Gemmill R.M., Lehner P.J. The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER. J. Cell Biol. 2009, 186:685-692.
25. Barel M.T., Pizzato N., van Leeuwen D., Bouteiller P.L., Wiertz E.J., Lenfant F. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. Eur. J. Immunol. 2003, 33:1707-1716.
26. Broxmeyer H.E., Dent A., Cooper S., Hangoc G., Wang Z.Y., Du W., Gervay-Haque J., Sriram V., Renukaradhya G.J., Brutkiewicz R.R. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus. Exp. Hematol. 2007, 35:87-93.
27. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997, 386:514-517.
28. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J., Wilkinson G.W. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287:1031.
29. Campos-Martin Y., Colmenares M., Gozalbo-Lopez B., Lopez-Nunez M., Savage P.B., Martinez-Naves E. Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells. J. Immunol. 2006, 176:6172-6179.
30. Campos-Martin Y., Gomez del Moral M., Gozalbo-Lopez B., Suela J., Martinez-Naves E. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. J. Immunol. 2004, 172:7297-7305.